• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Growth abnormality of paroxysmal nocturnal hemoglobinuria stem cell

Research Project

Project/Area Number 10670957
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKumamoto University

Principal Investigator

NAKAKUMA Hideki  Kumamoto University School of Medicine, Associate Professor, 医学部, 講師 (90207746)

Co-Investigator(Kenkyū-buntansha) KAWAGUCHI Tatsuya  Kumamoto University School of Medicine, Associate Prefessor, 医学部・附属病院, 講師 (50244116)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 1999: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 1998: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsparoxysmal nocturnal hemoglobinuria / stem cell / growth abnormality / 幹細胞 / 腫瘍性増殖 / 遺伝子
Research Abstract

Paroxysmal nocturnal hemoglobinuria (PNH)is an acquired stem cell disorder of a clonal nature that is characterized by various clinical manifestations such as intravascular hemolysis, thrombosis, and marrow failure, and leukemic conversion. Thc entire mechanism of the hemolysis characteristic of PNH has beeen recently clarified. However, the molecular events leading to other clinical manifestations are still unknown. To understand the complex pathophysiology of PNH, the nature of affected PNH clone needs to be uncovered. PNH cells often shows considerable clonal expansion despite its susceptibility to complement and finally occupies patient's bone marrow. Therefore, we expected a growth advantage of PNH clone over normal clones. In fact, hematopoietic progenitor cells obtained from PNH patients showed a preferential hematopoiesis when engrafted in severe combined immunodeficiency mice. To know a growth property of PNH clone, we investigated affected clones in patients with PNH-related … More stem cell disorders such as aplastic anemia (AA) and myelodysplastic syndromes (MDS). Detection frequency of PNH clone was 30% and 10% in patients with AA and MDS, respectively. In type and site of the PIG-A mutations that are responsible for membrane defect of PNH cells were heterogenous, similar to that observed in de novo PNH. There appeared no close correlation between PIG-A mutations and the expansion of PNH clone. Subsequently, we detected two gene fragments that showed predominant expression in PNH cells by mRNA differential display method. One was 700bp cDNA with a sequence like transcription factors, whereas another showed a similar nucleotide sequence to that of spermidine/spermine N1-acetyltransferase, an enzyme operating in polyamine metabolism. Further, we investigated microsatellite instability to explain the conditions favorable for emergence of mutated clones in patients with PNH. However, it appeared to be too uncommon to explain the mutable conditions. To gain insight into the conditions, additional mechanisms other than microsatellite instability need to bc explored. Less

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] Iwanaga M, 他8名: "paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes"Br J Haematol. 102. 465-474 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kawaguchi T, 他9名: "A novel type of factor XI deficiency showing compound genetic abnormalities: a nonsense mutation and an impaired transcription"Int J Hematol. 71. 84-89 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Li K, 他10名: "Rarity of microsatellite alterations in paroxysmal nocturnal haemoglobinuria"Eur J Haematol. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Iwanaga M, Furukawa K, Amenomori T, Mori H, Nakamura H, Fuchigami K, Kamihira S, Nakamura H, Tomonaga M: "Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes"Br J Haematol. 102. 465-474 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kawaguchi T, Koga S, Hongo H, Komiyama Y, Li K, Ishihara S, Horikawa K, Hidaka 9meM, Mitsuya H, Nakakuma H: "A novel type of factor XI deficiency showing compound genetic abnormalities: a nonsense mutation and an impaired transcription"Int J Hematol. 71. 84-89 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Li K, Kawaguchi T, Ishihara S, Horikawa K,Hidaka M, Sakaguchi M, Tsuruzaki R, Kawakita M, Kagimoto T, Mitsuya H, Nakakuma H: "Rarity of microsatellite alterations in paroxysmal nocturnal haemoglobinuria"Eur J Haematol. GD.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kawaguchi T、他9名: "A novel type of factor XI deficiency showing compound genetic abnormalities:a nonsense mutation and an impaired transcription."Int.J.Hematol.. 71. 84-89 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Li K,、他10名: "Rarity of microsatellite alterations in patients with paroxysmal nocturnal haemoglobinuria."Eur.J.Haematol.. (in press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Iwanana M,et al.: "Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes." Brit J Haematol. 102. 465-474 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi